ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
18/02/2026
Voltar para busca
Dado oficial do USPTO
T315I MUTATION TREATMENT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
79
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
42, 44
Data de depósito
15/01/2021
Data de registro
02/09/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
02/09/2025
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
3
Tipo de titular
11
Localização do titular
SAINT-LAURENT, CA
Examinador
KNIGHT, TROY FRANK
Unidade examinadora
L70
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of grey letters and numbers for "T315I" with the "3" being a swirl design where the outside is purple and the inside is orange and the words "MUTATION TREATMENT" are in purple title case letters with a purple plus sign in front of these words.
Titulares e representantes
Titulares
KNIGHT THERAPEUTICS INC.
ENDO OPERATIONS LIMITED
Paladin Labs Inc.
Representantes
Camille M. Miller COZEN O'CONNOR
Classificação técnica
Classes Nice
Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Providing scientific analysis and informational reports based upon results of laboratory testing in the field of kinase inhibitor treatment failuregeneticsepigenetics and cancer; Scientific research in the fields of kinase inhibitor treatment failuregeneticsepigenetics and cancer; Laboratory research in the field of the field of cancer researchkinase inhibitor treatment failuregenetics; Providing laboratory research services in the field of kinase inhibitor treatment failure and genetic testing
Classe 44
Medical testing for diagnostic and prognostic purposes in the field of cancerkinase inhibitor treatment failuregenetics; Medical testing for diagnostic and treatment purposes in the field of cancer researchkinase inhibitor treatment failure researchgenetics research; Providing medical information to medical professionalsoncologists and treating physicians for cancer patientsin the form of reports in the field of cancer diagnostics and prognostics; Medical testing serviceskinase inhibitor treatment failure and genetic testing for diagnosis and treatment of cancer; Genetic testing for medical purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
79 publicações encontradas
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/09/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
02/09/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15/07/2025
PUBO
PUBLISHED FOR OPPOSITION
15/07/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/07/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/06/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/06/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/06/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/06/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
19/04/2025
GNSL
LETTER OF SUSPENSION E-MAILED
19/04/2025
CNSL
SUSPENSION LETTER WRITTEN
19/04/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/04/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/04/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
08/04/2025
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
12/02/2025
GNSI
INQUIRY TO SUSPENSION E-MAILED
12/02/2025
CNSI
SUSPENSION INQUIRY WRITTEN
12/02/2025
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
04/02/2025
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
28/06/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
17/06/2024
GNSL
LETTER OF SUSPENSION E-MAILED
17/06/2024
CNSL
SUSPENSION LETTER WRITTEN
17/06/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/05/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/05/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
24/05/2024
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
23/05/2024
GNSI
INQUIRY TO SUSPENSION E-MAILED
23/05/2024
CNSI
SUSPENSION INQUIRY WRITTEN
23/05/2024
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
03/05/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/05/2024
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
21/02/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
20/08/2023
GNSL
LETTER OF SUSPENSION E-MAILED
20/08/2023
CNSL
SUSPENSION LETTER WRITTEN
20/08/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/06/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/06/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
09/06/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/06/2023
GNSL
LETTER OF SUSPENSION E-MAILED
08/06/2023
CNSL
SUSPENSION LETTER WRITTEN
08/06/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
06/04/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
07/09/2022
GNSL
LETTER OF SUSPENSION E-MAILED
07/09/2022
CNSL
SUSPENSION LETTER WRITTEN
07/09/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/08/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/08/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
25/08/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
24/08/2022
GNSL
LETTER OF SUSPENSION E-MAILED
24/08/2022
CNSL
SUSPENSION LETTER WRITTEN
24/08/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
29/07/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
29/07/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
29/07/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
29/07/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/07/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/07/2022
ALIE
ASSIGNED TO LIE
10/07/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
24/06/2022
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
22/06/2022
GNSI
INQUIRY TO SUSPENSION E-MAILED
22/06/2022
CNSI
SUSPENSION INQUIRY WRITTEN
22/06/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
21/06/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
01/06/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
27/10/2021
GNSL
LETTER OF SUSPENSION E-MAILED
27/10/2021
CNSL
SUSPENSION LETTER WRITTEN
27/10/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/08/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/08/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
17/08/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
16/08/2021
GNRT
NON-FINAL ACTION E-MAILED
16/08/2021
CNRT
NON-FINAL ACTION WRITTEN
16/08/2021
DOCK
ASSIGNED TO EXAMINER
27/07/2021
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
17/04/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
16/04/2021
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
14/04/2021
NWAP
NEW APPLICATION ENTERED
19/01/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace T315I MUTATION TREATMENT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.